Email this article 
Protein-Energy Malnutrition as a Predictor of Early Recurrent Revisions After Debridement Surgery in Patients With Difficult-to-Treat Periprosthetic Infection
- Authors: Bozhkova S.A.1, Liventsov V.N.1, Tikhilov R.M.1, Romano C.L.2, Kochish A.Y.1,3, Labutin D.V.1, Artyukh V.A.1
-
Affiliations:
- Vreden National Medical Research Center of Traumatology and Orthopedics
- Clinica San Gaudenzio
- Kirov Military Medical Academy
- Issue: Vol 28, No 1 (2022)
- Pages: 39-45
- Section: Clinical studies
- URL: https://journal.rniito.org/jour/article/view/1717
- DOI: https://doi.org/10.17816/2311-2905-1717
- ID: 1717
Cite item
Full Text
Abstract
Background. Protein-energy malnutrition (PEM) is an established risk factor of postoperative complications in orthopedic disorders, including arthroplasty of the large joints.
The study aimed to evaluate PEM prevalence and its association with the early postoperative revision in patients with the difficult-to-treat (DTT) prosthetic joint infection (PJI) of the hip.
Methods. The retrospective study included 132 patients with chronic DTT PJI of the hip. The patients underwent orthopedic implant removal, radical debridement of the infected tissues, and resection arthroplasty with non-free transplantation of an axial vastus lateralis muscle flap (n = 57) or installation of an antimicrobial spacer (n = 75). DTT PJI was defined as an infection caused by rifampicin-resistant staphylococcal strains, ciprofloxacin-resistant gram-negative bacteria, fungi of the genus Candida, and their associations. The assessment of the patient’s protein-energy status included the evaluation of reference laboratory parameters, such as levels of hemoglobin, total protein, and albumin and number of lymphocytes. The degree of PEM was determined by the number of laboratory markers below the threshold values. The statistical comparison was performed using Fisher’s test. The odds ratio (OR, 95% confidence interval [CI]) was calculated to assess the risk of PJI recurrence. Differences were considered significant at p<0.05.
Results. More than 70% of patients with chronic DTT PJI included in the study were diagnosed with preoperative PEM of varying degrees of severity. Hypoalbuminemia and decreased hemoglobin levels were diagnosed more often: 64.3% and 57.1% in the muscle flap plasty and 57.3% and 31.1% in the antimicrobial spacer group, respectively. In muscle plasty and antimicrobial spacer groups, a decrease in the values of three or more reference PEM markers was detected in 28.5% and 16.0% of patients, and this advanced impairment of the nutritional status increased the risk of early revision intervention by two (OR 2.0; CI 95% 0.47–8.56; p = 0.35) and six times (OR 6.11; 95% CI 1.06–35.35; p<0.04), respectively.
Conclusion. In general, the analysis of publications and results of our study show that PEM is associated with the development of surgical site infection and recurrence of PJI after revision surgery. A decrease in the values of three or more reference PEM markers is a significant predictor of repeated revisions after debridement surgery with the installation of an antimicrobial spacer. PEM complicates the postoperative course in patients with resection arthroplasty. Given the high incidence of PEM in patients with DTT PJI of the hip joint, further research is needed to develop methods for nutritional status correction and assessment of their effect on the outcomes of debridement surgery.
Full Text
Introduction
Chronic prosthetic joint infection (PJI) is one of the serious complications of total joint arthroplasty. The worst treatment results are observed in infections caused by drug-resistant strains of bacteria [1, 2]. Lately, the so-called difficult-to-treat (DTT) infection has been defined as an infection caused by difficult-to-eradicate pathogens such as rifampicin-resistant staphylococci, ciprofloxacin-resistant gram-negative bacteria and Candida fungi [3]. Multiple attempts to eradicate this infection through debridement surgery result in large bone defects. Resection arthroplasty of the hip coupled with a flap of vastus lateralis muscle filling the bone defect has been shown as an effective way to achieve the control of infection, particularly, in case of the DTT PJI and in some cases restore its function [4, 5]. This surgical approach improves the blood supply and the delivery of oxygen, leucocytes and antibiotics to the affected tissue which helps to eradicate pathogens responsible for the chronic infection decreasing the risk of PJI recurrence [6].
The imbalance of nutrients or protein-energy malnutrition (PEM) is one of the main causes of increased morbidity and mortality, reduced quality of life, increased frequency and length of hospital stay, and associated health care costs [7, 8]. PEM is a proven risk factor for the development of postoperative complications in orthopedics including patients who underwent arthroplasty of large joints as well as spinal surgery [9, 10, 11]. In addition, PEM not only negatively affects postoperative recovery and wound healing but also increases the risk of early and late surgical site infection [12]. The incidence of PEM in orthopedic patients requiring arthroplasty varies from 8.5% to 50% [13, 14, 15]. PEM has been shown both as a risk factor for the onset of prosthetic joint infection and a predictor of the infection recurrence after primary arthroplasty [16]. Surrogate markers of PEM such as total lymphocyte count, serum albumin and transferrin have been extensively used to assess the underlying nutritional status of patients [17, 18]. Increased risk of complications after total hip arthroplasty including the recurrence of PJI has been associated with hypoalbuminemia [19]. Low levels of albumin in combination with hemoglobin were also associated with the development of PJI [18].
The number of studies that have addressed the role of PEM in the development of PJI is limited. Most of them are hindered by heterogeneous cohorts without any discrimination between cases of primary and revision arthroplasty, or PJI and trauma-related surgery [15, 20]. Given this, we aimed to evaluate the prevalence of PEM in patients DTT PJI of the hip. In addition, the association of preoperative PEM with surgical complications requiring early postoperative revision after resection arthroplasty with a muscle flap or a cement spacer implantation was assessed.
Methods
The data for the study were retrieved from the records of the local PJI register covering the period of 2012–2018. The study was approved by the institutional review board. General informed consent was obtained as a part of the hospital admission.
Of all 132 patients included in the study, 57 were treated with a pedicled muscle flap after the removal of the endoprosthesis. Surgical debridement of the affected tissue was followed by subsequent transplantation of a vastus lateralis muscle flap of the femur retaining the vascular supply. Alternatively, the remaining 75 patients were treated with surgical debridement and installation of an antimicrobial cement spacer in place of the metal components.
The main inclusion criteria were chronic DTT PJI of the hip caused by rifampicin-resistant staphylococci, ciprofloxacin-resistant Gram-negative bacteria and/or Candida fungi. The main laboratory parameters which were taken for the evaluation of the nutritional status included total lymphocyte count, hemoglobin, albumin and total protein. The cut-off values suggesting PEM were defined as follows: total lymphocyte count (TLC) at <1.5×109 cells/L, hemoglobin at <12.0 g/dL, albumin at <3.5 g/dL and total protein at <6.5 g/dL. The severity of PEM was defined as the percentage of cases with one, two or three and more of these laboratory values below the cut-off level.
Postoperatively, all patients received intravenous antibiotic therapy followed by oral antibiotics for 6–8 weeks. The proportion of patients requiring revision surgery in the early postoperative period was evaluated regardless of the cause.
Statistic analysis
The data were analyzed using Statistica v 10 (StatSoft, Russia) and GraphPad Prism v 9.0 (GraphPad, USA). Categorical variables are shown as percentages. They were evaluated using Fischer’s exact test. Odds ratios (OR. were calculated with respective confidence intervals (CI) at the confidence level of 95%. The P-value below 0.05 was considered as the indication of statistical significance.
Results
General characteristics of the cohort are depicted in Figure 1. Patients treated with a muscle flap had a longer median duration of PJI and a lower percentage of at least two episodes of infection recurrence before the hospital admission as compared to patients managed using two-stage revision with a cement spacer.
Fig. 1. General characteristics of the cohort / Рис. 1. Общая характеристика пациентов
Hypoalbuminemia and decreased hemoglobin were the most common markers of malnutrition in the cohort (Fig. 2).
Fig. 2. Percentage of the decreased surrogate markers of protein-energy malnutrition in the cohort / Рис. 2. Доля пациентов со снижением уровня опорных показателей БЭН в группах сравнения
Whereas the overall fraction of patients with one abnormal malnutrition marker was comparable to those without PEM in the muscle flap group but higher in the cement spacer group (Fig. 3).
Fig. 3. Preoperative severity of the protein-energy malnutrition / Рис. 3. Частота встречаемости БЭН различной степени выраженности у пациентов групп сравнения
Association of the advanced malnutrition (at least three abnormal markers) and post-operative complications requiring surgical revision was only statistically evident in the cement spacer group (Fig. 4, 5).
Fig. 4. Association of protein-energy malnutrition and revision surgery in the muscle flap group / Рис. 4. Влияние степени выраженности БЭН на течение раннего послеоперационного периода в группе мышечной пластики
Fig. 5. Association of protein-energy malnutrition and revision surgery in the cement spacer group / Рис. 5. Влияние степени выраженности БЭН на течение раннего послеоперационного периода в группе антимикробного спейсера
Discussion
Despite the worse functional outcomes compared to the use of an antimicrobial spacer, resection arthroplasty of the hip joint using a vastus lateralis muscle flap is an effective procedure to achieve PJI control [4]. The cohort of patients in the present study has previously been assessed to compare the efficacy of resection arthroplasty with a muscle flap and a cement spacer implantation for treatment of DTT PJI [5]. In all patients with the muscle flap and cement spacer, the infection remission was achieved in 96.5% (n = 55) and 45.3% (n = 34) of cases, respectively. Late recurrence of PJI was only in 2.5% (n = 2) of cases with the muscle flap vs 26.7% (n = 20) of cases with a cement spacer. Thus, resection arthroplasty with a vastus lateralis muscle flap proved to be a strategy of choice for management of recurrent DTT PJI. In contrast, for this study, the cohort was analyzed both for the prevalence of preoperative PEM and the association of PEM with early postoperative complications requiring revision.
The average preoperative prevalence of PEM in patients undergoing arthroplasty depending on the heterogeneity of the cohort has been widely reported at 8.5%, 12.3%, 53% and 80% [13, 15, 15, 20, 21]. At the time of hospital admission, most of our patients (>70%) had laboratory signs of PEM. It is well known that prolonged systemic inflammatory response due to the persistent infection eventually leads to the loss of muscle mass and function, which could itself be the manifestation of PEM [7, 8]. For instance, cases of revision arthroplasty due to septic complications had a higher rate of hypoalbuminemia as compared to aseptic cases [10]. Given this, it is feasible to assume that long-term chronic DTT PJI with multiple prior failed revisions could have been the primary reason for the impaired preoperative nutritional status of our patients. This would also explain the rather high prevalence of PEM in our study compared to previous reports. It is noteworthy to mention that the already abnormal nutritional status of patients at the time of hospital admission could have also been further aggravated by the surgery.
Several laboratory values have been considered as surrogate markers for the early diagnosis of PEM. For instance, albumin and hemoglobin have been shown as independent factors associated with PJI occurrence after primary elective THA [18]. Whereas albumin had the highest specificity and a positive predictive value compared to all other markers such as total lymphocyte count and transferrin. Other studies have also confirmed the association of hypoalbuminemia with complications of arthroplasty from surgical site infection to pneumonia, cardiovascular pathology, and urinary tract infection [9, 21, 22, 23]. Like the above reports, our findings showed low albumin and hemoglobin as the most prevalent (>50%) abnormal laboratory values.
Our previous study showed that in the early postoperative period, the only indication for the secondary revision in the spacer group (28%, n = 21) was the recurrence of the infection. Alternatively, main indications (35%, n = 20) for post-operative revision in the muscle flap group were necrosis of the flap (8.8%, n = 5), culture-negative hematomas (10.5%, n = 6), and recurrence of the infection including wound dehiscence or prolonged wound drainage for more than 7 days (15.7%, n = 9) [5]. PEM was found to be associated with the prolonged surgical site discharge and subsequent deep infection which required additional treatment after elective total joint arthroplasty [16]. In our cohort, a decrease of 3 or more laboratory markers of PEM increased the risk of postoperative wound revision by 6 times in patients with a cement spacer (OR 6.11, CI95% 1.06–35.35, P<0.04) and 2 times in patients with a muscle flap (OR 2.0, CI95% 0.47-8.56, P = 0.35) (see Fig. 4, 5).
Due to the retrospective nature of our study, some medical records such as BMI index and a complete list of concomitant pathology were missing for a part of the cohort and thus were omitted from the analysis.
Enteral nutrition is a process of providing the patients with necessary supplements has been long regarded as a method of choice for PEM correction in general medicine and hip replacement in geriatric patients [24]. Unfortunately, due to the limited number of studies addressing potential benefits of PEM correction in orthopedic patients the exact guidelines for preventing early post-operative complications including PJI recurrence via nutritional supplementation before and after arthroplasty are yet to be established. In a clinical study of 162 cases of primary knee arthroplasty, it has been shown that patients with constant perioperative nutritional management had a lower number of postoperative complications such as wound drainage, hematomas, superficial and deep infection as well as the reduced number of albumin transfusions and a shorter hospital stay [25]. This suggests that implementing the protocols for hypoproteinemia correction before any major orthopedic surgery such as primary and revision arthroplasty including patients with PJI could improve its outcome.
Overall, both previous reports and our data show that malnutrition is associated with the occurrence of surgical site infection and relapse of PJI after revision arthroplasty. In particular, the risk of postoperative revision was significantly associated with multiple pathological markers of PEM in two-stage revision with a cement spacer but not with a muscle flap surgery. Considering the mounting evidence that malnutrition is a modifiable risk factor for PJI, more studies are required to demonstrate the efficacy of preoperative PEM correction.
Disclaimers
Authors’ contributions
Bozhkova S.A. — research concept and design, data statistical processing, manuscript writing and editing.
Liventsov V. N. — data collection and analysis, manuscript writing.
Tikhilov R.M. — research concept and design.
Carlo L. Romano — research concept and design, final manuscript editing.
Kochish A.Yu. — research concept and design.
Labutin D.V. — data statistical processing, manuscript writing.
Artyukh V.A. — treatment the patients, manuscript editing.
All authors have read and approved the final version of the manuscript of the article. All authors agree to bear responsibility for all aspects of the study to ensure proper consideration and resolution of all possible issues related to the correctness and reliability of any part of the work.
Funding source. The funding was provided by the Ministry of the Russian Federation grant No121041300195-3 «Experimental validation and clinical assessment of the approaches towards increasing the effectiveness of complex treatment of patients with periprosthetic infection».
Competing interests. The authors declare that they have no competing interests.
Ethics approval. Not applicable.
Consent for publication. Not required.
Дополнительная информация
Заявленный вклад авторов
Божкова С.А. — идея и дизайн исследования, написание и редактирование текста статьи, интерпретация полученных данных.
Ливенцов В.Н. — сбор, статистическая обработка данных, интерпретация полученных данных, написание текста статьи.
Тихилов Р.М. — концепция и дизайн исследования.
Романо К.Л. — концепция и дизайн исследования, редактирование текста статьи на английском языке.
Кочиш А.Ю. — концепция и дизайн исследования.
Лабутин Д.В. — статистическая обработка данных, написание текста статьи.
Артюх В.А. — ведение прооперированных больных, редактирование текста статьи.
Все авторы прочли и одобрили финальную версию рукописи статьи. Все авторы согласны нести ответственность за все аспекты работы, чтобы обеспечить надлежащее рассмотрение и решение всех возможных вопросов, связанных с корректностью и надежностью любой части работы.
Источник финансирования. Государственное задание № 056-00123-21-00, тема № 4 «Экспериментальное обоснование и клиническая оценка путей повышения эффективности комплексного лечения пациентов с перипротезной инфекцией».
Конфликт интересов. Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
Этическая экспертиза. Не применима.
Информированное согласие. Не требуется.
About the authors
Svetlana A. Bozhkova
Vreden National Medical Research Center of Traumatology and Orthopedics
Email: clinpharm-rniito@yandex.ru
ORCID iD: 0000-0002-2083-2424
Dr. Sci. (Med.), Head of the Research Department of Prevention and Treatment of Wound Infection and Department of Clinical Pharmacology
Russian Federation, 8, Akademika Baykova str., St. Petersburg, 195427Vitaly N. Liventsov
Vreden National Medical Research Center of Traumatology and Orthopedics
Author for correspondence.
Email: vnliventsov@yandex.ru
ORCID iD: 0000-0001-8748-2134
Cand. Sci. (Med.), Deputy Chief Medical Officer, orthopedic surgeon department of Purulent Surgery
Russian Federation, 8, Akademika Baykova str., St. Petersburg, 195427Rashid M. Tikhilov
Vreden National Medical Research Center of Traumatology and Orthopedics
Email: rtikhilov@gmail.com
ORCID iD: 0000-0003-0733-2414
Dr. Sci. (Med.), Professor
Russian Federation, 8, Akademika Baykova str., St. Petersburg, 195427Carlo L. Romano
Clinica San Gaudenzio
Email: info@carlolucaromano.com
ORCID iD: 0000-0001-6726-0593
MD, PhD, Professor, Orthopaedic Surgeon Consultant
Italy, NovaraAleksandr Yu. Kochish
Vreden National Medical Research Center of Traumatology and Orthopedics; Kirov Military Medical Academy
Email: auk1959@mail.ru
ORCID iD: 0000-0002-2466-7120
Dr. Sci. (Med.), Professor, Deputy Director for Science and education, Department of operative Surgery and Topographic anatomy
Russian Federation, 8, Akademika Baykova str., St. Petersburg, 195427; St. PetersburgDmitry V. Labutin
Vreden National Medical Research Center of Traumatology and Orthopedics
Email: mailbox@dlabutin.com
ORCID iD: 0000-0002-4405-7688
Research Assistant, Research Department of Prevention and Treatment of Wound Infection
Russian Federation, 8, Akademika Baykova str., St. Petersburg, 195427Vasily A. Artyukh
Vreden National Medical Research Center of Traumatology and Orthopedics
Email: artyukhva@mail.ru
ORCID iD: 0000-0002-5087-6081
Cand. Sci. (Med.), head of department of Purulent Surgery
Russian Federation, 8, Akademika Baykova str., St. Petersburg, 195427References
- Wimmer M.D., Hischebeth G.T.R., Randau T.M., Gathen M., Schildberg F.A., Fröschen F.S. et al. Difficult-to-treat pathogens significantly reduce infection resolution in periprosthetic joint infections. Diagn Microbiol Infect Dis. 2020;98(2):115114. doi: 10.1016/j.diagmicrobio.2020.115114.
- Giulieri S.G., Graber P., Ochsner P.E., Zimmerli W. Management of Infection Associated with Total Hip Arthroplasty according to a Treatment Algorithm. Infection. 2004;32(4):222-228. doi: 10.1007/s15010-004-4020-1.
- Винклер Т., Трампуш А., Ренц Н., Перка К., Божкова С.А. Классификация и алгоритм диагностики и лечения перипротезной инфекции тазобедренного сустава. Травматология и ортопедия России. 2016;(1):33-45. doi: 10.21823/2311-2905-2016-0-1-33-45. Winkler T., Trampuz A., Renz N., Perka C., Bozhkova S.A. Classification and algorithm for diagnosis and treatment of hip prosthetic joint infection. Travmatologiya i ortopediya Rossii [Traumatology and Orthopedics of Russia]. 2016;22(1):33-45. (In Russian). doi: 10.21823/2311-2905-2016-0-1-33-45.
- Suda A.J., Heppert V. Vastus lateralis muscle flap for infected hips after resection arthroplasty. J Bone Joint Surg Br. 2010;92(12):1654-1658. doi: 10.1302/0301-620X.92B12.25212.
- Ливенцов В.Н., Божкова С.А., Кочиш А.Ю, Артюх В.А., Разоренов В.Л., Лабутин Д.В. Трудноизлечимая ППИ тазобедренного сустава: результаты санирующих операций. Травматология и ортопедия России. 2019; 25(4):88-97. doi: 10.21823/2311-2905-2019-25-4-88-97. Liventsov V.N., Bozhkova S.A., Kochish A.Y., Artyukh V.A., Razorenov V.L., Labutin D.V. Difficult- To-Treat Periprosthetic Hip Infection: Outcomes of Debridment. Travmatologiya i ortopediya Rossii [Traumatology and Orthopedics of Russia]. 2019;25(4):88-97. (In Russian). doi: 10.21823/2311-2905-2019-25-4-88-97.
- Choa R., Gundle R., Critchley P., Giele H. Successful management of recalcitrant infection related to total hip replacement using pedicled rectus femoris or vastus lateralis muscle flaps. J Bone Joint Surg Br. 2011;93(6):751-754. doi: 10.1302/0301-620X.93B6.25726.
- Jensen G.L., Bistrian B., Roubenoff R., Heimburger D.C. Malnutrition Syndromes: A Conundrum vs Continuum. JPEN J Parenter Enteral Nutr. 2009;33(6):710-716. doi: 10.1177/0148607109344724.
- Jensen G.L., Mirtallo J., Compher C., Dhaliwal R., Forbes A., Figueredo GrijalbaR. et al. Adult starvation and disease-related malnutrition: A proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee. Clin Nutr. 2010;29(2):151-153. doi: 10.1016/j.clnu.2009.11.010.
- Walls J.D., Abraham D., Nelson C.L., Kamath A.F., Elkassabany N.M., Liu J. Hypoalbuminemia More Than Morbid Obesity is an Independent Predictor of Complications After Total Hip Arthroplasty. J Arthroplasty. 2015;30(12):2290-2295. doi: 10.1016/j.arth.2015.06.003.
- Bohl D.D., Shen M.R., Kayupov E., Cvetanovich G.L., Della Valle C.J. Is Hypoalbuminemia Associated With Septic Failure and Acute Infection After Revision Total Joint Arthroplasty? A Study of 4517 Patients From the National Surgical Quality Improvement Program. J Arthroplasty. 2016;31(5):963-967. doi: 10.1016/j.arth.2015.11.025.
- Adogwa O., Martin J.R., Huang K., Verla T., Fatemi P., Thompson P. et al. Preoperative Serum Albumin Level as a Predictor of Postoperative Complication After Spine Fusion. Spine (Phila Pa 1976). 2014;39(18): 1513-1519. doi: 10.1097/BRS.0000000000000450.
- Yu P.-J., Cassiere H.A., Dellis S.L,. Manetta F., Kohn N., Hartman A.R. Impact of Preoperative Prealbumin on Outcomes After Cardiac Surgery. JPEN J Parenter Enteral Nutr. 2015;39(7):870-874. doi: 10.1177/0148607114536735.
- Rai J., Gill S.S., Kumar B.R.J.S. The influence of preoperative nutritional status in wound healing after replacement arthroplasty. Orthopedics. 2002;25(4):417-421.
- Schwarzkopf R., Russell T.A., Shea M., Slover J.D. Correlation between nutritional status and Staphylococcus colonization in hip and knee replacement patients. Bull NYU Hosp Jt Dis. 2011;69(4):308-311.
- Huang R., Greenky M., Kerr G.J., Austin M.S., Parvizi J. The Effect of Malnutrition on Patients Undergoing Elective Joint Arthroplasty. J Arthroplasty. 2013;28(8 Suppl):21-24. doi: 10.1016/j.arth.2013.05.038.
- Jaberi F.M., Parvizi J., Bs C.T.H., Joshi A., Purtill J. Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty. Clin Orthop Relat Res. 2008;466(6):1368-1371. doi: 10.1007/s11999-008-0214-7.
- Cross M.B., Yi P.H., Thomas C.F., Garcia J., Della Valle C.J. Evaluation of malnutrition in orthopaedic surgery. J Am Acad Orthop Surg. 2014;22(3):193-199. doi: 10.5435/JAAOS-22-03-193.
- Blevins K., Aalirezaie A., Shohat N., Parvizi J. Malnutrition and the Development of Periprosthetic Joint Infection in Patients Undergoing Primary Elective Total Joint Arthroplasty. J Arthroplasty. 2018;33(9): 2971-2975. doi: 10.1016/j.arth.2018.04.027.
- Rynecki N.D., Congiusta D.V., Fields M., Patel R., Vosbikian M.M., Ahmed I.H. Increased risk of complications in patients with hypoalbuminemia undergoing revision total hip arthroplasty. J Orthop. 2020;21:253-257. doi: 10.1016/j.jor.2020.03.006.
- Yi P.H., Frank R.M., Vann E., Sonn K.A., Moric M., Della Valle C.J. Is Potential Malnutrition Associated With Septic Failure and Acute Infection After Revision Total Joint Arthroplasty? Clin Orthop Relat Res. 2015;473(1): 175-182. doi: 10.1007/s11999-014-3685-8.
- Eminovic S., Vincze G., Eglseer D., Riedl R., Sadoghi P., Leithner A. et al. Malnutrition as predictor of poor outcome after total hip arthroplasty. Int Orthop. 2021;45(1):51-56. doi: 10.1007/s00264-020-04892-4.
- Kamath A.F., McAuliffe C.L., Kosseim L.M., Pio F., Hume E. Malnutrition in Joint Arthroplasty: Prospective Study Indicates Risk of Unplanned ICU Admission. Arch Bone Jt Surg. 2016;4(2):128-131.
- Tsantes A.G., Papadopoulos D.V., Lytras T., Tsantes A.E., Mavrogenis A.F., Korompilias A.V. et al. Association of malnutrition with periprosthetic joint and surgical site infections after total joint arthroplasty: a systematic review and meta-analysis. J Hosp Infect. 2019;103(1): 69-77. doi: 10.1016/j.jhin.2019.04.020.
- Volkert D., Berner Y.N., Berry E., Cederholm T., Coti Bertrand P., Milne A. et al. ESPEN Guidelines on Enteral Nutrition: Geriatrics. Clin Nutr. 2006;25(2): 330-360. doi: 10.1016/j.clnu.2006.01.012.
- Cao G., Huang Q., Xu B., Huang Z., Xie J., Pei F. Multimodal Nutritional Management in Primary Total Knee Arthroplasty: A Randomized Controlled Trial. J Arthroplasty. 2017;32(11):3390-3395. doi: 10.1016/j.arth.2017.06.020.
Supplementary files
